Physician profile
Roger William Strunk
NPI 1063411650
$1,229.22
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $518 · 2022: $711.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $243.50 | 2021-2022 | |
| Glaxosmithkline, LLC. | $155.03 | 2021-2022 | |
| Novo Nordisk INC | $149.11 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.07 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $116.76 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.11 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.15 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $43.87 | 2022 | |
| Janssen Pharmaceuticals, INC | $38.62 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $35.18 | 2022 | |
| Merck Sharp & Dohme LLC | $34.04 | 2022 | |
| Medtronic, INC. | $33.39 | 2021-2022 | |
| Amgen INC. | $29.17 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $27.68 | 2021-2022 | |
| Eisai INC. | $20.42 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $18.56 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.78 | 2021 | |
| Dexcom, INC. | $13.84 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.94 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Strunk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.